v3.25.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series C Conversion
Series B Conversion
Preferred Class B
Common Stock
Common Stock
Series C Conversion
Common Stock
Series B Conversion
Preferred Stock
Preferred Class B
Preferred Stock
Preferred Class B
Series C Conversion
Preferred Stock
Preferred Class B
Series B Conversion
Preferred Stock
Preferred Class C
Additional Paid-in Capital
Additional Paid-in Capital
Series C Conversion
Additional Paid-in Capital
Series B Conversion
Accumulated Other Comprehensive Income (Loss)
Retained (Deficit) Earnings
Non-controlling Interest
Non-controlling Interest
Series B Conversion
Common stock, Beginning balance (in shares) at Dec. 31, 2022         26,462,000                          
Preferred stock, Beginning balance (in shares) at Dec. 31, 2022               0     0              
Beginning balance, including noncontrolling interest at Dec. 31, 2022 $ 707,244       $ 265     $ 0     $ 0 $ 270,855     $ 0 $ 436,124 $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net (loss) income 167,351                             167,351    
Foreign currency translation adjustments 0                                  
Common stock issued under employee stock purchase plan (in shares)         11,000                          
Common stock issued under employee stock purchase plan 800                     800            
Share-based compensation expense 12,012                     12,012            
Payment of dividends to shareholders (24,995)                     18       (25,013)    
Payment of minimum tax withholdings on share-based awards (in shares)         (40,000)                          
Payment of minimum tax withholdings on share-based awards (4,340)                             (4,340)    
Repurchases and retirement of common stock (in shares)         (883,000)                          
Repurchases and retirement of common stock (93,811)       $ (9)                     (93,802)    
Issuance of share-based awards (in shares)         121,000                          
Issuance of share-based awards 0       $ 1             (1)            
Common stock, Ending balance (in shares) at Dec. 31, 2023         25,671,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2023               0     0              
Ending balance, including noncontrolling interest at Dec. 31, 2023 764,261       $ 257     $ 0     $ 0 283,684     0 480,320 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net (loss) income (1,131,228)                             (816,969) (314,259)  
Foreign currency translation adjustments (2,732)                           (2,732)      
Shares issued - acquisition (in shares)         700,000     4,000                    
Shares issued - acquisition 617,128       $ 7             205,510         411,611  
Common stock issued under employee stock purchase plan (in shares)         44,000                          
Common stock issued under employee stock purchase plan 753                     753            
Share-based compensation expense 10,188                     10,188            
Payment of minimum tax withholdings on share-based awards (in shares)         (43,000)                          
Payment of minimum tax withholdings on share-based awards (1,442)                             (1,442)    
Issuance of share-based awards (in shares)         170,000                          
Issuance of share-based awards 0       $ 2             (2)            
Share conversions (in shares)           1,210,000 2,009,000   8,000 (2,000)                
Share conversions   $ 0 $ 29,104     $ 12 $ 20           $ (12) $ 42,296       $ (13,212)
Tax receivable agreement liability and other adjustment $ (164)                     (25)       (139)    
Common stock, Ending balance (in shares) at Dec. 31, 2024 29,761,197       29,761,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2024 0     10,088       10,000     0              
Ending balance, including noncontrolling interest at Dec. 31, 2024 $ 285,868       $ 298     $ 0     $ 0 542,392     (2,732) (338,230) 84,140  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net (loss) income (141,725)                             (107,796) (33,929)  
Foreign currency translation adjustments 4,320                           3,312   1,008  
Common stock issued under employee stock purchase plan (in shares)         34,000                          
Common stock issued under employee stock purchase plan 846                     846            
Share-based compensation expense 13,429                     13,429            
Payment of minimum tax withholdings on share-based awards (in shares)         (38,000)                          
Payment of minimum tax withholdings on share-based awards (1,074)                             (1,074)    
Issuance of share-based awards (in shares)         242,000                          
Issuance of share-based awards $ 0       $ 2             (2)            
Share conversions (in shares)             1,328,000     (1,000)                
Share conversions     $ 0       $ 13             $ 2,886       $ (2,899)
Common stock, Ending balance (in shares) at Dec. 31, 2025 31,326,561       31,327,000                          
Preferred stock, Ending balance (in shares) at Dec. 31, 2025 0     8,760       9,000     0              
Ending balance, including noncontrolling interest at Dec. 31, 2025 $ 161,664       $ 313     $ 0     $ 0 $ 559,551     $ 580 $ (447,100) $ 48,320